Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 148, Issue 1, 2014, Pages 36-40

  Cooke, David T ^a,b   Gandara, David R ^b   Goodwin, Neal C ^c   Calhoun, Royce F ^a   Lara, Primo N ^b   Mack, Philip C ^b   David, Elizabeth A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Jackson Laboratories (JAX WEST)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURGERY; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); ELECTIVE SURGERY; FEASIBILITY STUDY; FEMALE; HEMATOTHORAX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; MALE; MEDIASTINOSCOPY; ONCOLOGY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERIOPERATIVE PERIOD; PLEURA BIOPSY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL INFECTION; THORAX SURGERY; THORAX WALL; TUMOR BIOPSY; URINARY TRACT INFECTION; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ADULT; AGED; BIOPSY; CALIFORNIA; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; FEASIBILITY STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INDIVIDUALIZED MEDICINE; LUNG NEOPLASMS; LYMPH NODE EXCISION; MALE; MEDIASTINOSCOPY; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; THORACIC SURGERY, VIDEO-ASSISTED; TIME FACTORS; TREATMENT OUTCOME;

EID: 84902533353     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.03.014     Document Type: Article

References (17)

1. D.S. Schrump, G. Giaccone, C.R. Kelsey, and L.B. Marks Non-small cell lung cancer V.T. DeVita, T.S. Lawrence, S.A. Rosenberg, DeVita, Hellman, and Rosenberg's Cancer: Principles and Practices of Oncology 2008 Lippincott Williams and Wilkins Philadelphia 896 945
2. L.C. Villaruz, and M.A. Socinski Personalized therapy for non-small cell lung cancer: which drug for which patient? Semin Thorac Cardiovasc Surg 23 2011 281 290
3. E.L. Kwak, Y.J. Bang, D.R. Camidge, A.T. Shaw, B. Solomon, and R.G. Maki et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 2010 1693 1703
4. K.A. Olaussen, A. Dunant, P. Fouret, E. Brambilla, F. André, V. Haddad IALT Bio Investigators DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 2006 983 991
5. N.I. Lindeman, P.T. Cagle, M.B. Beasley, D.A. Chitale, S. Dacic, and G. Giaccone et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology J Thorac Oncol 8 2013 823 859
6. M. Reck, A. Hermes, E.H. Tan, E. Felip, B. Klughammer, and J. Baselga Tissue sampling in lung cancer: a review in light of the MERIT experience Lung Cancer 74 2011 1 6
7. C.L. Coghlin, L.J. Smith, S. Bakar, K.N. Stewart, G.S. Devereux, and M.C. Nicolson et al. Quantitative analysis of tumor in bronchial biopsy specimens J Thorac Oncol 5 2010 448 452
8. Y.C. Cheung, J.W. Chang, J.J. Hsieh, G. Lin, and Y.H. Tsai Adequacy and complications of computed tomography-guided core needle biopsy on non-small cell lung cancers for epidermal growth factor receptor mutations demonstration: 18-gauge or 20-gauge biopsy needle Lung Cancer 67 2010 166 169
9. V. Blackhall, M. Asif, A. Renieri, S. Civitelli, A. Kirk, and A. Jilaihawi et al. The role of surgical lung biopsy in the management of interstitial lung disease: experience from a single institution in the UK Interact Cardiovasc Thorac Surg 17 2013 253 257
10. C.J. Lettieri, G.R. Veerappan, D.L. Helman, C.R. Mulligan, and A.F. Shorr Outcomes and safety of surgical lung biopsy for interstitial lung disease Chest 127 2005 1600 1605
11. C.D. Wright, H.A. Gaissert, J.D. Grab, S.M. O'Brien, E.D. Peterson, and M.S. Allen Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk-adjustment model Ann Thorac Surg 85 2008 1857 1865
12. F. Farjah, D.E. Wood, T.K. Varghese, N.N. Massarweh, R.G. Symons, and D.R. Flum Health care utilization among surgically treated Medicare beneficiaries with lung cancer Ann Thorac Surg 88 2009 1749 1756
13. K. Ohashi, Y.E. Maruvka, F. Michor, and W. Pao Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease J Clin Oncol 31 2013 1070 1080
14. C.J. Chow, E.B. Habermann, A. Abraham, Y. Zhu, S.M. Vickers, and D.A. Rothenberger et al. Does enrollment in cancer trials improve survival? J Am Coll Surg 216 2013 774 780
15. A.T. Shaw, B.Y. Yeap, B.J. Solomon, G.J. Riely, J. Gainor, and J.A. Engelman et al. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis Lancet Oncol 12 2011 1004 1012
16. M. Maemondo, A. Inoue, K. Kobayashi, S. Sugawara, S. Oizumi, H. Isobe North-East Japan Study Group Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR N Engl J Med 362 2010 2380 2388
17. D.S. Ettinger, W. Akerley, H. Borghaei, A.C. Chang, R.T. Cheney, and L.R. Chirieac et al. Non-small cell lung cancer, version 2.2013 J Natl Compr Canc Netw 11 2013 645 653